Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ...
Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine, the ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its Covid ...
Moderna said that the European Patent Office had decided to maintain the validity of one of the company's key patents ...
Though Covid sales have dropped, the market for mRNA vaccines is expected to grow to around $40bn by 2033, according to data published by Precedence Research. The EPO verdict on Moderna’s patent win ...
NEW YORK (Reuters) – Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key ...
London: Moderna announced on Friday that it has emerged victorious in a case at the European Patent Office against Pfizer and ...
Moderna MRNA-Q said on Friday the European Patent Office had upheld the validity of one of the company’s key patents, a win in an ongoing COVID-19 vaccine dispute with Pfizer PFE-N and BioNTech ...
(Reuters) -Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine, the company said on Friday. “We are pleased to announce that the ...